Friday, June 9, 2023
HomeNewsHealth Think Tank has developed a medicine that keeps weight down surprisingly

Health Think Tank has developed a medicine that keeps weight down surprisingly


Related stories

US Think Tank Challenges Assumption: More Spending Doesn’t Mean More Security

This research article explores the notion that increased defense...

Think Tank Study: Michigan’s Climate Haven Potential Demands Action

Michigan, known for its abundance of natural resources and...

France Stands with Pakistan: EUR 3.5 Million Grant Bolsters WFP’s Fight Against Malnutrition

The United Nations World Food Programme (WFP) expresses gratitude...

Influential Think Tank ISSI Drives Dialogue on AfCFTA through Round Table Discussion

In a collaborative effort, the African Missions in Pakistan...

UAE Under Fire for Alleged Think Tank Manipulation of COP28 Preparations

The United Arab Emirates (UAE), one of the world's...

A joint think tank from three research institutions has achieved a significant single milestone in developing a weight-loss maintenance medicine.

Many health problems can be solved by reducing the weight of the human body. American scientists have found a unique solution to this problem, with the help of which weight loss can be brought about with the help of normal diet.

Interestingly researchers at UT Health San Antonio, along with collaborators from the University of Pennsylvania and Cornell University, successfully, have prepared a small-molecule drug called CPACC that limits magnesium transport in cellular power plants called mitochondria.

Durring research, this medicine has been shown to prevent weight gain and adverse liver changes in mice on a high-sugar, high-fat diet. It is fact that by reducing magnesium transport in the mitochondria, the drug enhances metabolism of sugar and fat, resulting in slimmer and healthier mice with no evidence of fatty liver disease.

The researchers have filed a patent application for the drug, which has potential implications in reducing the risk of cardiometabolic diseases and liver cancer.

With the help of this drug, the severity of many other related diseases can also be reduced but a little caution is required.

A health think tank is preparing to launch a clinical trial of a drug derived from this research.

Zain Saleem
Zain Saleem
Zain Saleem, Islamabad News Editor and work for THE THINK TANK JOURNAL

Latest stories




Please enter your comment!
Please enter your name here